Continuous Subcutaneous Insulin Infusion Market, By Product Type, By Patient Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Continuous subcutaneous insulin infusion market size was valued at USD 4,245 Million in 2023, expanding at a CAGR of 9.89% from 2024 to 2032.

Continuous subcutaneous insulin infusion (CSII) is a diabetes management method that uses an insulin pump to deliver small, continuous doses of rapid-acting insulin under the skin. This method mimics the body's natural insulin release, which helps in maintaining stable blood glucose levels. Patients can adjust doses for meals or exercise, offering flexibility and better glycemic control. CSII is especially beneficial for individuals with type 1 diabetes who require precise insulin regulation throughout the day and night.

Continuous Subcutaneous Insulin Infusion Market- Market Dynamics

Growing awareness about advanced insulin delivery devices to propel market demand

The continuous subcutaneous insulin infusion (CSII) market is driven by rising diabetes rates and increased awareness of advanced insulin delivery, with 40% of type 1 diabetes patients currently using insulin pumps. However, high healthcare costs and limited accessibility may hamper the industry's growth. On the contrary, Opportunities lie in AI and IoT innovations that enhance pump functionality and patient experience, alongside the advancement of artificial pancreas systems which promise expanded data integration and improved glucose control.

Continuous Subcutaneous Insulin Infusion Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.89% over the forecast period (2024-2032)

Based on product type segmentation, tethered pump was predicted to show maximum market share in the year 2023

Based on patient type segmentation, type 1 was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Continuous Subcutaneous Insulin Infusion Market- Segmentation Analysis:

The Global Continuous Subcutaneous Insulin Infusion Market is segmented based on Product Type, Patient Type, End-use, and Region.

The market is divided into three categories based on product type: patch pumps and tethered pumps. The tethered pumps sector dominates the market. The air-to-air heat pump requires very little maintenance and is simple to install. It is chosen over ground source heat pump systems since there are no groundwork costs and it is more cost-effective.

The market is divided into two categories based on patient type: type 1 and type 2. The type 1 sector dominates the market and is likely to maintain its dominance during the forecast period. This is majorly due to its accessibility and portability, capturing a significant market share. These devices, easily worn under or outside clothing, offer convenience for insulin management.

Continuous Subcutaneous Insulin Infusion Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Continuous Subcutaneous Insulin Infusion Market- Competitive Landscape:

The global market is driven by the growing adoption of advanced insulin management solutions, emphasizing user-friendly technology and improved glycemic control. Market strategies include partnerships to enhance device integration with glucose monitoring systems, enabling real-time data and predictive analytics for proactive diabetes management. Additionally, companies are focusing on developing compact, discreet insulin pumps and customizable dosing options to cater to specific patient needs, particularly in managing type 1 diabetes across diverse demographics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Medtronic Inc.
CeQur
Tandem Diabetes Care
F Hoffmann-La Roche
Ypsomed
Insulet Corporation
Sooil Development
Valeritas Inc.
Cellenovo
B. Braun Melsungen AG
Bigfoot Biomedical, Inc.
Becton, Dickinson and Company
Fresenius SE & Co. KGaA
MicroPort Scientific Corporation
MannKind Corporation
Nipro Corporation
Shinmyung Mediyes CO., LTD.
Sanofi S.A.
Smiths Group PLC
Others

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Patch Pumps
Bolus
Basal
Basal & Bolus
Tethered Pumps
Battery
Insulin Set Insertion Devices
Insulin Reservoir & Cartridges

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

Type 1
Type 2

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Laboratories
Homecare
Hospitals

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4325

1. Continuous Subcutaneous Insulin Infusion Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Continuous Subcutaneous Insulin Infusion Market Snippet by Product Type
- 2.1.2. Continuous Subcutaneous Insulin Infusion Market Snippet by Patient Type
- 2.1.3. Continuous Subcutaneous Insulin Infusion Market Snippet by End-use
- 2.1.4. Continuous Subcutaneous Insulin Infusion Market Snippet by Country
- 2.1.5. Continuous Subcutaneous Insulin Infusion Market Snippet by Region
2.2. Competitive Insights

3. Continuous Subcutaneous Insulin Infusion Key Market Trends

3.1. Continuous Subcutaneous Insulin Infusion Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Continuous Subcutaneous Insulin Infusion Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Continuous Subcutaneous Insulin Infusion Market Opportunities
3.4. Continuous Subcutaneous Insulin Infusion Market Future Trends

4. Continuous Subcutaneous Insulin Infusion Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Continuous Subcutaneous Insulin Infusion Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Continuous Subcutaneous Insulin Infusion Market Landscape

6.1. Continuous Subcutaneous Insulin Infusion Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Continuous Subcutaneous Insulin Infusion Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2. Patch Pumps
  - 7.1.2.1. Basal & Bolus
  - 7.1.2.2. Basal
  - 7.1.2.3. Bolus
- 7.1.3. Tethered Pumps
  - 7.1.3.1. Battery
  - 7.1.3.2. Insulin Set Insertion Devices
  - 7.1.3.3. Insulin Reservoir & Cartridges

8. Continuous Subcutaneous Insulin Infusion Market - By Patient Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
- 8.1.2. Type 1
- 8.1.3. Type 2

9. Continuous Subcutaneous Insulin Infusion Market - By End-use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-use, 2023 & 2032 (%)
- 9.1.2. Laboratories
- 9.1.3. Homecare
- 9.1.4. Hospitals

10. Continuous Subcutaneous Insulin Infusion Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Continuous Subcutaneous Insulin Infusion Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Medtronic Inc.
- 11.2.2. CeQur
- 11.2.3. Tandem Diabetes Care
- 11.2.4. F Hoffmann-La Roche
- 11.2.5. Ypsomed
- 11.2.6. Insulet Corporation
- 11.2.7. Sooil Development
- 11.2.8. Valeritas Inc.
- 11.2.9. Cellenovo
- 11.2.10. B. Braun Melsungen AG
- 11.2.11. Bigfoot Biomedical, Inc.
- 11.2.12. Becton, Dickinson and Company
- 11.2.13. Fresenius SE & Co. KGaA
- 11.2.14. MicroPort Scientific Corporation
- 11.2.15. MannKind Corporation
- 11.2.16. Nipro Corporation
- 11.2.17. Shinmyung Mediyes CO., LTD.
- 11.2.18. Sanofi S.A.
- 11.2.19. Smiths Group PLC
- 11.2.20. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us